Drug­maker to sell cheaper ri­val to EpiPen

Ledger-Enquirer - - Business -

Generic drug­maker San­doz an­nounced plans Thurs­day to start selling a slightly cheaper ver­sion of the EpiPen in the U.S. early next year.

The pen­like in­jec­tors are used to halt life-threat­en­ing al­ler­gic re­ac­tions to in­sect bites, nuts and other foods. Brand-name EpiPen, which dom­i­nates the mar­ket, has been in short sup­ply since spring be­cause of pro­duc­tion prob­lems.

San­doz will sell a pair of in­jec­tors, un­der the name Sym­jepi, for $250 with­out in­sur­ance. Two other gener­ics on the mar­ket in the U.S. cost $300 a pair, in­clud­ing one from EpiPen seller My­lan.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.